Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(updated hyperlink) |
(Added 4 new pathways) |
||
| Line 35: | Line 35: | ||
[http://www.ncbi.nlm.nih.gov/pubmed/25277212 Leung et al. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential] | [http://www.ncbi.nlm.nih.gov/pubmed/25277212 Leung et al. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential] | ||
|width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | |width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | ||
| + | |- | ||
| + | |width=100px|{{#pwimage:Pathway:WP3592|250px||ApoE and miR-146 in inflammation and atherosclerosis}} | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/25904598 Li et al. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis] | ||
| + | |width=100px|{{#pwimage:Pathway:WP3593|250px||miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma}} | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/25903473 Wong et al. The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma] | ||
| + | |width=100px|{{#pwimage:Pathway:WP3595|250px||mir-124 predicted interactions with cell cycle and differentiation}} | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/26655797 Shields et al. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression] | ||
| + | |width=100px|{{#pwimage:Pathway:WP3596|250px||miR-517 relationship with ARCN1 and USP1}} | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/26655797 Shields et al. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression] | ||
|- | |- | ||
|width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} | |width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} | ||
Revision as of 20:15, 21 January 2016
|
Image does not exist T-Cell Receptor and Co-stimulatory Signaling |
Image does not exist IL1 and megakaryotyces in obesity |
Image does not exist RNA interference Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist Extracellular vesicle-mediated signaling in recipient cells |
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist mir34a and TGIF2 in osteoclastogenesis |
Image does not exist mir219 in Oligodendrocyte Differentiation and Myelination |
Image does not exist Apoptosis-related network due to altered Notch3 in ovarian cancer |
|
Image does not exist miR-222 in Exercise-Induced Cardiac Growth |
Image does not exist Hypoxia-mediated EMT and Stemness |
Image does not exist DDX1 as a regulatory component of the Drosha microprocessor |
Image does not exist EV release from cardiac cells and their functional effects Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future? |
|
Image does not exist Rac1/Pak1/p38/MMP-2 pathway Gonzalez-Villasana et al. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer |
Image does not exist eIF5A regulation in response to inhibition of the nuclear export system Miyake et al. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A |
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist Signaling Pathways in Glioblastoma |
|
Image does not exist ApoE and miR-146 in inflammation and atherosclerosis |
Image does not exist miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma |
Image does not exist mir-124 predicted interactions with cell cycle and differentiation |
Image does not exist miR-517 relationship with ARCN1 and USP1 |
|
Image does not exist miRs in Muscle Cell Differentiation |
Image does not exist REBF and miR33 in cholesterol and lipid homeostasis |
Image does not exist SRF and miRs in Smooth Muscle Differentiation and Proliferation |
Image does not exist Mecp2 and Associated Rett Syndrome |
|
Image does not exist Cell Differentiation |
Image does not exist Endoderm Differentiation |
Image does not exist Ectoderm Differentiation |
Image does not exist Mesodermal Commitment Pathway |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Mir302-367 Promoting Cardiomyocyte Proliferation |
Image does not exist Alzheimers Disease |
Image does not exist Parkinsons Disease |
|
Image does not exist MicroRNAs in cardiomyocyte hypertrophy |
Image does not exist Integrated Lung Cancer Pathway |
Image does not exist miRNA Biogenesis |
Image does not exist miRNA targets in ECM and membrane receptors |
|
Image does not exist Fluoropyrimidine Activity |
Image does not exist miRNAs involved in DNA damage response |
Image does not exist Metastatic Brain Tumor |
Image does not exist Regulatory RNA pathways |
|
Image does not exist Spinal Cord Injury |
Image does not exist miRNA Regulation of DNA Damage Response |
Image does not exist miR-targeted genes in leukocytes - TarBase |
Image does not exist miR-targeted genes in squamous cell - TarBase |
|
Image does not exist Metastatic brain tumor |
Image does not exist TarBasePathway |
Image does not exist miR-targeted genes in adipocytes - TarBase |
Image does not exist miR-targeted genes in epithelium - TarBase |
|
Image does not exist miR-targeted genes in lymphocytes - TarBase |
Image does not exist miR-targeted genes in muscle cell - TarBase |
